ALPMY — ASTELLAS PHARMA INC ADR
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 7 SEC-registered investment managers reported holding ALPMY (ASTELLAS PHARMA INC ADR) in their latest 13F filings, with a combined reported value of $3.05M across 227.50K shares. That is -5.7% by share count (-13.55K shares) versus the previous quarter, while reported value moved -22.0%. Ownership is concentrated: the five largest holders account for 99.7% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 added to existing stakes, 4 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ASTELLAS PHARMA INC ADR (ALPMY) include RENAISSANCE GROUP LLC, HANTZ FINANCIAL SERVICES, INC., LANARK FINANCIAL, INC., ranked by reported 13F value among the 16 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 6 | 210.50K | $3.05M | -6.4% |
| Q2 2026 | 7 | 227.50K | $3.05M | -5.7% |
| Q1 2026 | 7 | 284.63K | $4.59M | -6.8% |
| Q4 2025 | 8 | 305.61K | $4.07M | -4.0% |
| Q3 2025 | 8 | 317.23K | $3.45M | +27.6% |
| Q2 2025 | 8 | 250.68K | $2.45M | +1.5% |
| Q1 2025 | 4 | 200.67K | $1.94M | +0.3% |
| Q4 2024 | 4 | 199.99K | $1.93M | -3.4% |
Over the 8 quarters shown, institutional share counts increased 5% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (+27.6%).
Top Institutional Holders (Q3 2026) — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 170.42K | $2.47M | 0.03% | Reduce | |
| 22.11K | $319.99K | 0.00% | Add | |
| 13.51K | $195.50K | 0.01% | Add | |
| 4.17K | $60.37K | 0.00% | Add | |
| 208 | $3.01K | 0.00% | New | |
| 70 | $1.01K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 189.33K | $2.53M | 0.03% | Reduce | |
| 21.64K | $289.35K | 0.00% | Reduce | |
| 12.43K | $166.24K | 0.01% | Reduce | |
| 2.02K | $31.94K | 0.02% | Hold | |
| 1.28K | $17.09K | 0.00% | New | |
| 734 | $9.57K | 0.00% | Reduce | |
| 70 | $936 | 0.00% | Add |
Q1 2026 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 200.70K | $3.25M | 0.05% | Reduce | |
| 44.86K | $710.25K | 0.05% | Reduce | |
| 21.80K | $353.66K | 0.00% | Reduce | |
| 12.77K | $207.15K | 0.01% | Add | |
| 2.43K | $40.08K | 0.00% | Add | |
| 2.02K | $26.99K | 0.02% | Add | |
| 56 | $908 | 0.00% | Hold |
Q4 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 217.43K | $2.89M | 0.04% | Reduce | |
| 51.36K | $685.81K | 0.05% | Reduce | |
| 23.41K | $311.09K | 0.00% | Reduce | |
| 10.84K | $144.06K | 0.01% | Add | |
| 1.49K | $19.84K | 0.01% | New | |
| 734 | $9.99K | 0.00% | Reduce | |
| 289 | $3.86K | 0.00% | Add | |
| 56 | $744 | 0.00% | Hold |
Q3 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 225.19K | $2.45M | 0.04% | Add | |
| 57.05K | $618.30K | 0.05% | Add | |
| 24.85K | $270.32K | 0.00% | Reduce | |
| 8.74K | $95.09K | 0.01% | Add | |
| 817 | $9.00K | 0.00% | Add | |
| 301 | $3.27K | 0.00% | New | |
| 224 | $2.43K | 0.00% | Hold | |
| 56 | $609 | 0.00% | Hold |
Q2 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 165.30K | $1.61M | 0.03% | Add | |
| 44.54K | $436.00K | 0.04% | New | |
| 31.14K | $303.59K | 0.00% | Reduce | |
| 7.17K | $69.93K | 0.00% | Add | |
| 2.23K | $21.86K | 0.00% | New | |
| 224 | $2.20K | 0.00% | New | |
| 56 | $546 | 0.00% | Reduce | |
| 18 | $174 | 0.00% | New |
New Positions (Q2 2026)
- First Command Advisory Services, Inc. 1.28K sh · $17.09K
Fully Exited (vs previous quarter)
- LANARK FINANCIAL, INC. sold 44.86K sh · $710.25K
Fund Position History — shares by quarter (top 16 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HANTZ FINANCIAL SERVICES, INC. | 170.42K | 189.33K | 200.70K | 217.43K | 225.19K | 165.30K | 161.89K | 157.05K | 163.97K | 157.91K | 128.70K | 112.59K | 41.58K | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 22.11K | 21.64K | 21.80K | 23.41K | 24.85K | 31.14K | 33.87K | 35.95K | 36.83K | 33.59K | 37.92K | 34.44K | 34.76K | — | — | — | — | — | — | — |
| GAMMA Investing LLC | 13.51K | 12.43K | 12.77K | 10.84K | 8.74K | 7.17K | 4.86K | 6.96K | 6.18K | 3.31K | 2.40K | 249 | — | — | — | — | — | — | — | — |
| First Command Advisory Services, Inc. | 4.17K | 1.28K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Ascentis Wealth Management, LLC | 208 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PNC Financial Services | 70 | 70 | 56 | 56 | 56 | 56 | 57 | 40 | 40 | 40 | 307 | 253 | 166 | 172 | 150 | 124 | 315 | 144 | 43 | 35 |
| RENAISSANCE GROUP LLC | — | — | — | — | — | — | — | — | — | — | — | — | 391.75K | — | — | — | — | — | — | — |
| LANARK FINANCIAL, INC. | — | — | 44.86K | 51.36K | 57.05K | 44.54K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MAI Capital Management | — | — | — | — | — | — | — | — | — | — | — | — | 19.09K | — | — | — | — | — | — | — |
| Salomon & Ludwin, LLC | — | 734 | 2.43K | 734 | 817 | 18 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WELLINGTON-ALTUS USA INC. | — | 2.02K | 2.02K | 1.49K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Brooklyn Investment Group | — | — | — | — | — | 2.23K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Russell Investments Group, Ltd. | — | — | — | — | — | — | — | — | — | — | — | — | 783 | — | — | — | — | — | — | — |
| Wealth Preservation Advisors, LLC | — | — | — | 289 | 224 | 224 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Steigerwald, Gordon & Koch Inc. | — | — | — | — | 301 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operose Advisors LLC | — | — | — | — | — | — | — | — | — | — | 90 | 90 | 90 | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ALPMY?
As of 2026-Q2, 7 institutional funds reported holding ALPMY (ASTELLAS PHARMA INC ADR) in SEC 13F filings, with a combined reported value of $3.05M.
How many shares of ALPMY do institutions own?
13F filers reported 227.50K shares of ALPMY, worth $3.05M in aggregate at the end of 2026-Q2.
Is institutional ownership of ALPMY rising or falling?
Share counts moved -5.7% versus the prior quarter — distribution.
Who are the top institutional holders of ALPMY?
The largest 13F holders are RENAISSANCE GROUP LLC, HANTZ FINANCIAL SERVICES, INC., LANARK FINANCIAL, INC., RHUMBLINE ADVISERS, MAI Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of ASTELLAS PHARMA INC ADR?
The major shareholders of ASTELLAS PHARMA INC ADR (ALPMY) by reported 13F value are RENAISSANCE GROUP LLC, HANTZ FINANCIAL SERVICES, INC., LANARK FINANCIAL, INC., RHUMBLINE ADVISERS, MAI Capital Management, among 16 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.